Tooba Rehman: Extending Impella 5.5 Support Beyond 14 Days in Cardiogenic Shock
Tooba Rehman, Medical Doctor, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Delighted to share my latest publication:
Impact of Impella 5.5 Duration Support and Clinical Outcomes in Cardiogenic Shock: A Systematic Review and Meta-Analysis
Cardiogenic shock remains one of the most challenging conditions we manage, and optimizing mechanical circulatory support strategies is critical.
In our latest meta-analysis (1,440 patients across 5 studies), we explored whether extending Impella 5.5 support beyond 14 days offers meaningful clinical benefits.
Grateful to my Amazing Team!”
Title: Impact of Impella 5.5 Duration Support and Clinical Outcomes in Cardiogenic Shock: Evidence from a Systematic Review and Meta-Analysis of Observational Studies
Authors: Mrunalini Dandamudi, Srinivas Vunnamb, Tooba Rehman, Muhammad Aqib Faizan, Miguel A Samaniego-Laguna, John Cedric Mojica, Juliana Giorgi
Read the Full Article on JHTL OPEN

Muhammad Aqib Faizan, Clinical Intern at District Headquarter Hospital, MTI, DIKhan, shared this post, adding:
“Significantly higher risk of implant-site hematoma and infection necessitates meticulous vascular management, infection-prevention strategies and close clinical surveillance.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC